Literature DB >> 2424995

Antigenic specificities of Pseudomonas aeruginosa alkaline protease and elastase defined by human T cell clones.

M J Parmely, R T Horvat.   

Abstract

Virulent strains of Pseudomonas aeruginosa derive their pathogenicity, in part, from their secretion of two proteolytic enzymes, alkaline protease (AP) and elastase (E). Human T lymphocytes specific for AP and E can be detected in the blood of immune donors and have afforded the opportunity to characterize the antigenicity of these proteins. To accomplish this goal, we have recently selected 68 human T cell clones from five different Pseudomonas-immune donors and determined their fine specificities. Fifty-five (81%) were found to be protease specific, demonstrating the immunogenicity of the exoenzymes in humans. These clones defined five AP and three E specificities and suggested the existence of at least five allomorphic determinants expressed on the proteases of various Pseudomonas strains. Limiting dilution analysis confirmed a number of antigenic relationships suggested by the long-term T cell clones and revealed that T cells specific for allomorphic protease determinants were at least as frequent in the blood of immune donors as were T cells committed to conserved determinants. Thus, both primary and long-term human T cell clones showed specificity patterns that distinguished proteases from different Pseudomonas strains. These observations describe a heretofore unknown antigenic system of Pseudomonas aeruginosa that should assist in defining the nature and specificity of Pseudomonas immunity in humans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

2.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Proteolytic inactivation of cytokines by Pseudomonas aeruginosa.

Authors:  M Parmely; A Gale; M Clabaugh; R Horvat; W W Zhou
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Inactivation of human gamma interferon by Pseudomonas aeruginosa proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin.

Authors:  R T Horvat; M Clabaugh; C Duval-Jobe; M J Parmely
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

Review 5.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

6.  Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.

Authors:  T G Theander; A Kharazmi; B K Pedersen; L D Christensen; N Tvede; L K Poulsen; N Odum; M Svenson; K Bendtzen
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

7.  Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

Authors:  R T Horvat; M J Parmely
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.